Outcomes of the study combining necitumumab and abemaciclib in patients with NSCLC
Benjamin Besse, MD, PhD from the Institute Gustave Roussy, Villejuif, France, discusses the outcomes of the recent phase 1b study of necitumumab in combination with abemaciclib in patients with stage ...
Author: VJHemOnc
Added: 05/17/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts